close

3P PrEP Trial Recruiting in Masiphumelele

17 October 2017

The Desmond Tutu HIV Foundation has launched a trial for young women who want the HIV-prevention medication, PrEP. This oral pill, which stands for pre-exposure prophylaxis (prophylaxis means prevention) is taken once a day and prevents the user from HIV infection. The details of the study are below, along with who is eligible to join the study and how to apply. ...

Read more

Recognising Gender Violence is Key to Ending HIV

17 October 2017

Everyone has heard of the different ways that HIV can spread: unprotected sex, sharing needles and childbirth to name a few. But, there is another dangerous perpetrator of HIV that is less obvious: violence against women. Violence against women is a social structure that helps spread HIV infection. It works by affecting women’s ability to negotiate when they have sex, what HIV prevention tool...

Read more

DTHF Partners with Coral Healthcare

16 October 2017

Coral Healthcare (India & Australia) have undertaken to provide their top quality condoms to the DTHF as their commitment to being, “proactive doers in the worlds in which we function”. We eagerly look forward to the first consignment that should arrive at the end of October. An Agreement has been signed between the DTHF and Coral Healthcare whereby Coral Healthcare condoms will reach i...

Read more

Women test discrete HIV prevention options

4 October 2017

A daily pill, a monthly vaginal ring or an injection every two months: These were the prevention options available to young women on the uChoose study to help them prevent HIV infection. Brady Hooley, from the Desmond Tutu HIV Foundation, presented the findings of this study. There are many new prevention tools becoming avai...

Read more

HIV Cure Symposium: Experts Speak on the Elusive Cure for HIV

2 October 2017

Key figures leading the fight against HIV discussed the status of the elusive HIV cure. Chaired by Prof Linda-Gail Bekker, Chief Operations Officer at the Desmond Tutu HIV Foundation, the speakers discussed why we need an HIV cure, is a cure possible and what that cure might look like.  [caption id="attachment_5888" align="aligncenter" width="300"]...

Read more

The Only Man Cured of HIV, Timothy Ray Brown, Speaks

2 October 2017

Only one man has ever been cured of HIV. Timothy Ray Brown has been living ten years since an extremely dangerous procedure that removed all the HIV in his body. Frequently referred to as the 'Berlin Patient' based on the city the procedure was performed in, Brown came to the "Is an HIV Cure possible?" symposium at the Desmond Tutu HIV Foundation in Cape Town to add to the discussion on the curren...

Read more

Dolutegravir Access: Achieved!

22 September 2017

At the UN General Assembly meeting Michel Sidibe, Executive Director of UNAIDS, announced that an exciting new pricing agreement has been made to accelerate the availability of the first affordable, generic, single-pill HIV treatment, which will contain Dolutegravir. ...

Read more

Pill Fatigue in PrEP is the Biggest Challenge in Fighting HIV in Adolescents

11 September 2017

The Plus Pills study, led by Professor Bekker, is a part of a three-part study examining PrEP use in different groups. PrEP, which stands for PreExposure Prophylaxis, is an HIV prevention drug that can be taken by HIV-negative people to protect them from infec...

Read more

Busting Myths about PrEP

11 September 2017

 PrEP is an everyday pill that an HIV negative person can take to prevent getting HIV. Consistent use is essential for protection. Since PrEP is still a relatively new advancement in HIV prevention technology, there are still a lot of concerns and misconceptions around it. Fortunately, there has been a flurry of research in the drug and Prof Linda-Gail Bekker, COO of the Desmond Tutu HIV Foun...

Read more

More Prevention Action Needed for MSM – The Sibanye Study

5 September 2017

Men who have sex with men (MSM) are a population at high risk of HIV infection. In order to end HIV, we need targeted prevention strategies for this key population and the Sibanye study has been researching just that. The Sibanye study recorded the uptake of a package of HIV prevention tools in MSM in sites around South Africa...

Read more

Why do Some Children Struggle to Adhere to HIV Treatment?

28 August 2017

This week, we were fortunate to have a visit from Sabine Van Elsland from the Desmond and Leah Tutu Legacy Foundation and VU University, who spoke about her research involving HIV positive children and how they respond to HIV treatment. Getting antiretroviral therapy (ART) to youths is one challenge, however, that is only the first challenge to overcome. An HIV positive person has to take daily me...

Read more

Researchers Present at IAS 2017

15 August 2017

The International AIDS Symposium (IAS) Conference 2017 was a wealth of cutting edge research and discussion on HIV and AIDS, and the representatives from the Desmond Tutu HIV Foundation (DTHF) were no exception.   Opening the conference was our own Prof Linda-Gail Bekker, the IAS President and International Scientific Chair of IAS 2017. Bekker spoke about the need to maintain levels of ...

Read more